BioPlex 2200 Autoimmune Panels

A multiplex assay for detection of clinically relevant antinuclear antibodies used in the diagnosis of systemic rheumatic diseases.

The BioPlex2200 Celiac IgA kit is a multiplex flow immunoassay for the semi-quantitative detection of IgA autoantibodies to deamidated gliadin peptide (DGP) and tissue Transglutaminase (tTG), aiding in the diagnosis of Celiac Disease<

The BioPlex2200 Celiac IgG kit is a multiplex flow immunoassay for the semi-quantitative detection of IgG autoantibodies to deamidated gliadin peptide (DGP) and tissue Transglutaminase (tTG), aiding in the diagnosis of Celiac Disease

BioPlex2200 APLS IgG test kit simultaneously detects two autoantibodies (anti-Cardiolipin IgG and anti-Beta-2 Glycoprotein I IgG), aiding in the diagnosis of Antiphospholipid Syndrome (APS)

BioPlex2200 APLS IgM test kit simultaneously detects two autoantibodies (anti-Cardiolipin IgM and anti-Beta-2 Glycoprotein I IgM), aiding in the diagnosis of Antiphospholipid Syndrome (APS)

BioPlex2200 APLS IgA test kit simultaneously detects two autoantibodies (anti-Cardiolipin IgA and anti-Beta-2 Glycoprotein I IgA), aiding in the diagnosis of Antiphospholipid Syndrome (APS)

Allows fully automated detection of clinically relevant antibodies (anti-MPO, anti-PR3 and anti-GBM) associated with systemic small vessel vasculitis and the renal disorder Goodpasture's syndrome on the BioPlex 2200 system

The BioPlex2200 Anti-CCP kit is a multiplex flow immunoassay for the semi-quantitative detection of IgG antibodies to cyclic citrullinated peptide (CCP) in human serum and EDTA or heparinized plasma. Used to aid in diagnosis of rheuma